Monopar Therapeutics Inc. · NASDAQ:MNPR
Saturn V Capital Management LP reported a 5.20% stake in Monopar Therapeutics Inc. (Schedule 13G)
Event Jan 5, 2026 · Filed May 15, 2026
Saturn V Capital Management LP reported a 5.20% stake in Monopar Therapeutics Inc., 345,626 shares, as a passive investor on Jan 5, 2026. Filed May 15, 2026 (Schedule 13G).
- Stake
- 5.20%
- Shares
- 345,626
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Saturn V Capital Management LP | 5.20% | 345,626 |
| Xiaoying Tian | 5.20% | 345,626 |
Source
Related
- Monopar Therapeutics Inc.
- Saturn V Capital Management LP
- Monopar Therapeutics Inc. shareholders
- Schedule 13G/A · Saturn V Capital Management LP · Aug 12, 2026
- Form 4 · Robinson Chandler · Oct 20, 2026
- Form 4 · Starr Christopher M · Oct 5, 2026
- Form 4 · Cittadine Andrew · Oct 2, 2026
- Form 4 · Vu Quan Anh · Oct 2, 2026
- Form 4 · Robinson Chandler · Oct 2, 2026